Literature DB >> 14681929

Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus.

Lorise C Gahring1, Karina Persiyanov, Diane Dunn, Robert Weiss, Erin L Meyer, Scott W Rogers.   

Abstract

The response by individuals to nicotine is likely to reflect the interaction of this compound with target nAChRs. However, resolving how different genetic backgrounds contribute to unique mouse strain-specific responses to this compound remains an important and unresolved issue. To examine this question in detail, expression of the nicotine acetylcholine receptor (nAChR) subunits alpha3, alpha4, alpha5, alpha7, beta2, and beta4 was measured in the dorsal hippocampus using immunohistochemistry in mouse strains or lines BALB/c, C3H/J, C57BL/6, CBA/J, DBA/2, Long Sleep (LS), Short Sleep (SS), and CF1. The nAChRs in all mice colocalized with glutamic acid decarboxylase (GAD)-positive interneurons that were subclassified into at least four groups based on nAChR subunit heterogeneity. A notable difference between mouse strains was the expression of nAChRs by astrocyte subpopulations in CA1 subregions whose numbers vary inversely with nAChR-immunostained neurons. This novel relationship also correlated with published parameters of strain sensitivity to nicotine. Attempts to identify the origin of this significant difference in nAChR expression among strains included comparison of the entire nAChRalpha4 gene sequence. Although multiple polymorphisms were identified, including two that changed nAChRalpha4 amino acid coding, none of these clearly correlate with strain-related differences in cell type-specific nAChR expression. These findings suggest that mouse strain-specific behavioral and physiological responses to nicotine are likely to be a reflection of a complex interplay between genetic factors that shape differences in expression and cellular architecture of this modulatory neurotransmitter system in the mammalian nervous system. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14681929     DOI: 10.1002/cne.10943

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  36 in total

Review 1.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

2.  Chronic nicotine treatment differentially modifies acute nicotine and alcohol actions on GABA(A) and glutamate receptors in hippocampal brain slices.

Authors:  William R Proctor; Peter Dobelis; Anna T Moritz; Peter H Wu
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 3.  Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory.

Authors:  Munir Gunes Kutlu; Thomas J Gould
Journal:  Physiol Behav       Date:  2015-12-11

4.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 5.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence.

Authors:  Lingjun Zuo; Yunlong Tan; Chiang-Shan R Li; Zhiren Wang; Kesheng Wang; Xiangyang Zhang; Xiandong Lin; Xiangning Chen; Chunlong Zhong; Xiaoping Wang; Jijun Wang; Lu Lu; Xingguang Luo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-07-30       Impact factor: 3.568

Review 7.  Glial-neuronal interactions--implications for plasticity and drug addiction.

Authors:  Sukumar Vijayaraghavan
Journal:  AAPS J       Date:  2009-02-24       Impact factor: 4.009

8.  Ethnicity-Dependent Effects of Schizophrenia Risk Variants of the OLIG2 Gene on OLIG2 Transcription and White Matter Integrity.

Authors:  Hiroshi Komatsu; Hikaru Takeuchi; Yoshie Kikuchi; Chiaki Ono; Zhiqian Yu; Kunio Iizuka; Yuji Takano; Yoshihisa Kakuto; Shunichi Funakoshi; Takashi Ono; Junko Ito; Yasuto Kunii; Mizuki Hino; Atsuko Nagaoka; Yasushi Iwasaki; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Hirotsugu Azechi; Noriko Kudo; Ryota Hashimoto; Hirooki Yabe; Mari Yoshida; Yuko Saito; Akiyoshi Kakita; Nobuo Fuse; Ryuta Kawashima; Yasuyuki Taki; Hiroaki Tomita
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

Review 9.  Natural genetic variability of the neuronal nicotinic acetylcholine receptor subunit genes in mice: Consequences and confounds.

Authors:  Jennifer A Wilking; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

10.  Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.

Authors:  Geeta Sharma; Sukumar Vijayaraghavan
Journal:  Subst Abuse       Date:  2008-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.